Skip to main content
. 2020 Mar 17;9(1):1738813. doi: 10.1080/2162402X.2020.1738813

Table 1.

Characteristics and contents of PLGA nanoparticles used in the study

Name Size (nm) SD (nm) Antigen (µg/mg NP) IMM60 content (ng/mg NP) NP Dose (mg)/mouse
NP (OVA-vivo750) 211 60 42 N.A. 1
NP (OVA-vivo750+ IMM60) 205 65 56 118 ± 3 0.74
NP (OVA) 236 83 35 N.A. 0.187–0.0187
NP (OVA+ IMM60) 232 66 39 162 ± 10 0.172–0.0172
NP (IMM60) 176 47 N.A. 1080 ± 38 0.2
NP(HPV-16 E7 SP+IMM60) 171 38 14,9 268 0.9